The Impact of Sedation Depth Monitoring for Cognitive Functions and Early Rehabilitation After Major Joints Arthroplasty
Conditions: Total Knee Replacement Surgery Interventions: Device: Dr äger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidien, Ireland); Device: Dräger Infinity Delta series monitor (Dräger, Germany) with Covidien BIS LoC 2 channel module and BIS Quatro (4 electrodes) sensor (Covidi en, Ireland) Sponsors: Lithuanian University of Health Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
The " CAD-Man " EXTEND Study
Conditions: Coronary Artery Disease Interventions: Diagnostic Test: CT; Diagnostic Test: invasive coronary angiography (ICA) Sponsors: Charite University, Berlin, Germany Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Paracetamol Impact Study: Prostaglandin Synthesis and Blood Pressure Effects (PIS-PaB)
Conditions: Pain Interventions: Other: routine clinical treatment of pain with paracetamol or ibuprofen Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Paracetamol Efffect on Prostaglandins and Blood Pressure
Conditions: Pain Interventions: Other: routine clinical treatment of pain with paracetamol or ibuprofen Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
Conditions: Haemodialysis; Chronic Kidney Disease Requiring Chronic Dialysis; Cardiovascular Disease; Cardiovascular Risk Factor; Hyperoxalemia Interventions: Drug: Lumasiran Sponsors: Charite University, Berlin, Germany; Alnylam Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Oxytocin and Reward Processing in Women
Conditions: Menstrual Cycle; Hormonal Contraception Interventions: Drug: Intranasal oxytocin administration; Drug: Intranasal placebo administration Sponsors: International Research Training Group 2804; University Hospital Tuebingen; German Research Foundation; Uppsala University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Stress Reactivity and Hormonal Contraception
Conditions: Hormonal Contraception Interventions: Other: Combined oral contraception; Other: Discontinuation of a combined oral contraception Sponsors: University Hospital Tuebingen; Uppsala University; German Research Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Patient Survey as a Tool to Quality Assurance and Quality Improvement 2024
Conditions: Patient Satisfaction Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Increasing transcultural competence in clinical psychologists through a web-based training: study protocol for a randomized controlled trial
DiscussionThis randomized controlled trial tests the efficacy of and satisfaction with a web-based training on transcultural competence for German-speaking clinical psychologists. If validated successfully, the training can represent a time- and place-flexible training opportunity that could be integrated into the continuing education of clinical psychologists in the long term.Trial registrationDRKS00031105. Registered on 21 February 2023. (Source: Trials)
Source: Trials - January 20, 2024 Category: Research Source Type: clinical trials
Comparison of Bulk-Fill Composite Resins in Class II Restorations
Conditions: Class II Restorations Interventions: Device: VisCalor Bulk,VOCO,Germany; Device: Admira Fusion x-tra,VOCO,Germany; Device: Filtek One Bulk,3M,Germany Sponsors: Hacettepe University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Delusion Ideation in the Context of Everyday Life
Conditions: Psychotic Disorder Interventions: Behavioral: Blended face-to-face and smartphone intervention Sponsors: Charite University, Berlin, Germany; Deutscher Akademischer Austausch Dienst; Swinburne University of Technology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis —study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
This study aims to evaluate the efficacy and safety of MTX in maintaining remission in patients with GCA who have previously been treated with GC and at least 6 months with TCZ. We hypothesize that MTX can maintain remission in GCA patients, who have achieved stable remission after treatment with GC and TCZ, and prevent the occurrence of relapses. The study design is a monocentric, randomized, double-blind, placebo-controlled, parallel-group phase II tria l randomizing 40 GCA patients 1:1 into a MTX or placebo arm. Patients will receive 17.5 mg MTX/matching placebo weekly by subcutaneous injection for 12 months, with t...
Source: Trials - January 15, 2024 Category: Research Source Type: clinical trials
Respiratory Physiotherapy as a Tool to Increase the Number of Solid Organ Donors
Conditions: Lung Transplant Failure Interventions: Device: MIE Sponsors: Vall d ' Hebron Institute Research; Hospital Vall d ' Hebron; Germans Trias i Pujol Hospital; Hospital Universitario Marqu és de Valdecilla Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Estradiol and Stress Reactivity in Women
Conditions: Stress vs. Control; Estradiol vs. Placebo Interventions: Drug: Estradiol Valerate; Drug: Placebo Sponsors: International Research Training Group 2804; University Hospital Tuebingen; German Research Foundation; Uppsala University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Bayer ’s AskBio initiates Phase II GenePHIT trial in Congestive Heart Failure (CHF)
Berlin, Germany/Research Triangle Park, North Carolina, USA, January 11, 2024– Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, have announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 11, 2024 Category: Pharmaceuticals Source Type: clinical trials
